Editorial: Immune response to respiratory viruses and respiratory viral infections in susceptible populations

Paraskevi C Fragkou; Dimitra Dimopoulou; Giulia De Angelis; Giulia Menchinelli; Roy F Chemaly; Chrysanthi Skevaki

doi:10.3389/fmed.2023.1330265

Editorial: Immune response to respiratory viruses and respiratory viral infections in susceptible populations

Front Med (Lausanne). 2023 Nov 17:10:1330265. doi: 10.3389/fmed.2023.1330265. eCollection 2023.

Authors

Paraskevi C Fragkou^#^{1

2}, Dimitra Dimopoulou^#^{2

3}, Giulia De Angelis^{2

4

5}, Giulia Menchinelli^{2

4}, Roy F Chemaly^{2

6}, Chrysanthi Skevaki^{2

7}

Affiliations

¹ 1st Department of Critical Care Medicine and Pulmonary Services, Evaggelismos General Hospital, Athens, Greece.
² European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Basel, Switzerland.
³ 2nd University Department of Pediatrics, Panagiotis & Aglaia Kyriakou Children's Hospital, Athens, Greece.
⁴ Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy.
⁵ Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
⁶ University of Texas MD Anderson Cancer Center, Houston, TX, United States.
⁷ Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center, Marburg, Germany.

^# Contributed equally.

No abstract available

Keywords: critical illness; immunodeficiency; immunology; immunosuppression; respiratory viral infections.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. CS was supported by the Universities Giessen and Marburg Lung Center (UGMLC), the German Center for Lung Research (DZL), University Hospital Giessen and Marburg (UKGM) research funding according to article 2, section 3 cooperation agreement, and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-SFB 1021 (Project Number 197785619), KFO 309 (Project Number 284237345), and SK 317/1-1 (Project Number 428518790) as well as by the Foundation for Pathobiochemistry and Molecular Diagnostics.